TROP Tool

TROP Tool

Supported byDaiichi Sankyo (Hong Kong) Limited

Lung Cancer

For registered Hong Kong doctors
Rethinking Biomarkers: Continuous Quantitative Scoring as an Emerging Tool for Oncologic Decision-MakingOncologyRethinking Biomarkers: Quantitative Continuous Scoring as an Emerging Tool for Oncologic Decision-MakingThe use of IHC staining of tissue samples to guide targeted treatment is widely used in clinical practice, and is recommended by expert groups for many tumor types and biomarkers. The classical approach to IHC scoring for biomarkers, such as human epidermal growth factor receptor-2 (HER2), classifies specimens as either ‘positive’ or ‘negative’, scoring samples as IHC0, 1+, 2+ or 3+ per pathologists’ visual interpretation.16 Jun 2026Sponsored